The measles, mumps, rubella vaccines market is being reported on, with some outlets providing information on its size and growth prospects up to 2034. There are also reports on related markets, including combination vaccines, live attenuated vaccines, and the global vaccine market. The size of the measles, mumps, rubella vaccine market is projected to reach a certain value, possibly around usd 4.53 billion by 2035, although exact figures and forecasts vary across reports.